|
1
|
Block IK, Koch CA, Mead NM, et al: Impact
of antioxidant supplementation on chemotherapeutic efficacy: A
systematic review of the evidence from randomized controlled
trials. Cancer Treat Rev. 33:407–418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Drisko AJ, Chapman J and Hunter JV: The
use of antioxidant therapies during chemotherapy. Gynecol Oncol.
88:434–439. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Teicher BA, Schwartz JL, Holden SA, Ara G
and Northey D: In vivo modulation of several anticancer agents by
β-carotene. Cancer Chemoth Pharmacol. 34:235–241. 1994. View Article : Google Scholar
|
|
4
|
Mackerras D, Irwig L, Simpson JM, et al:
Randomized double-blind trial of beta-carotene and vitamin C in
women with minor cervical abnormalities. Brit J Cancer.
79:1448–1453. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lamson DW and Brignall MS: Antioxidants
and cancer therapy II: quick reference guide. Altern Med Rev.
5:152–163. 2000.PubMed/NCBI
|
|
6
|
Rama B and Prasad KN: Study on the
specificity of α-tocopheryl (vitamin E) acid succinate effects on
the melanoma, glioma and neuroblastoma cells in culture. Proc Soc
Exp Biol Med. 174:302–307. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Azzi A, Gysin R, Kempná P, et al: The role
of α-tocopherol in preventing disease: from epidemiology to
molecular events. Mol Aspects Med. 24:325–336. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shiff SJ, Koutsos MI, Qiao L and Rigas B:
Nonsteroidal antiinflammatory drugs inhibit the proliferation of
colon adenocarcinoma cells: effects on cell cycle and apoptosis.
Exp Cell Res. 222:179–188. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith ML, Hawcroft G and Hull MA: The
effect of non-steroidal anti-inflammatory drugs on human colorectal
cancer cells: evidence of different mechanisms of action. Eur J
Cancer. 36:664–674. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cuzick J, Otto F, Baron JA, et al: Aspirin
and non-steroidal anti-inflammatory drugs for cancer prevention: an
international consensus statement. Lancet Oncol. 10:501–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gupta RA, Tan J, Krause WF, et al:
Prostacyclin-mediated activation of peroxisome peroxiome
proliferator-activated receptor delta in colorectal cancer. Proc
Natl Acad Sci USA. 97:13275–13280. 2000. View Article : Google Scholar
|
|
12
|
Yasumaru M, Tsuji S, Tsujii M, et al:
Inhibition of angiotensin II activity enhanced the antitumor effect
of cyclooxygenase-2 inhibitors via insulin-like growth factor I
receptor pathway. Cancer Res. 63:6726–6734. 2003.PubMed/NCBI
|
|
13
|
Bernardi A, Jacques-Silva MC,
Delgado-Cañedo A, Lenz G and Battastini AMO: Nonsteroidal
anti-inflammatory drugs inhibit the growth of C6 and U138-MG glioma
cell lines. Eur J Pharmacol. 532:214–222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Amin R, Kamitani H, Sultana H, et al:
Aspirin and indomethacin exhibit antiproliferative effects and
induce apoptosis in T98G human glioblastoma cells. Neurol Res.
25:370–376. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Holt S and Fowler CJ: Anandamide
metabolism by fatty acid amide hydrolase in intact C6 glioma cells.
Increased sensitivity to inhibition by ibuprofen and flurbiprofen
upon reduction of extra but not intracellular pH. Naunyn
Schmiedebergs Arch Pharmacol. 367:237–244. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ribeiro G, Benadiba M, Colquhoun A and
Silva DO: Diruthenium (II, III) complexes of ibuprofen, aspirin,
naproxen and indomethacin non-steroidal anti-inflammatory drugs:
Synthesis, characterization and their effects on tumor-cell
proliferation. Polyhedron. 27:1131–1137. 2008. View Article : Google Scholar
|
|
17
|
Lee BS, Nalla AK, Stock IR, et al:
Oxidative stimuli-responsive nanodrug of camptothecin kills
gliobalstoma cells. Bioorg Med Chem Lett. 20:5262–5268. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shono T, Tofilon PJ, Bruner JM, Owolabi O
and Lang FF: Cyclooxygenase-2 expression in human gliomas:
prognostic significance and molecular correlations. Cancer Res.
61:4375–4381. 2001.PubMed/NCBI
|
|
19
|
Kürzel F, Hagel Ch, Zapf S, et al:
Cyclo-oxygenase inhibitors and thromboxane synthase inhibitors
differentially regulate migration arrest, growth inhibition and
apoptosis in human glioma cells. Acta Neurochir (Wien). 144:71–87.
2002. View Article : Google Scholar
|
|
20
|
Nathoo N, Barnett GH and Golubic M: The
eicosanoid cascade: possible role in gliomas and meningiomas. J
Clin Pathol. 57:6–13. 2004. View Article : Google Scholar
|
|
21
|
New P: Cyclooxygenase in the treatment of
glioma: its complex role in signal transduction. Cancer Control.
11:152–164. 2004.PubMed/NCBI
|
|
22
|
Wang M, Yoshida D, Liu S and Teramoto A:
Inhibition of cell invasion by indomethacin on glioma cell lines:
in vitro study. J Neurooncol. 72:1–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grubbs CJ, Lubet RA, Koki AT, et al:
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced
urinary bladder cancers in male B6D2F1 mice and female Fischer-344
rats. Cancer Res. 60:5599–5602. 2000.PubMed/NCBI
|
|
24
|
Williams CS, Watson AJM, Sheng H, et al:
Celecoxib prevents tumor growth in vivo without toxicity to normal
gut: lack of correlation between in vitro and in vivo models.
Cancer Res. 60:6045–6051. 2000.PubMed/NCBI
|
|
25
|
Baek JS, Wilson CL, Lee CH and Eling TE:
Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs):
inhibition of cyclooxygenase and induction of NSAID-activated gene.
J Pharmocol Exp Ther. 301:1126–1131. 2002. View Article : Google Scholar
|
|
26
|
Shiff SJ, Shivaprasad P and Santini DL:
Cyclooxygenase inhibitors: drugs for cancer prevention. Curr Opin
Pharmacol. 3:352–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival application to proliferation and
cytotoxicity assay. J Immunol Methods. 65:551983. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Negre-Salvayre A, Augé N, Duval C, et al:
Detection of intracellular reactive oxygen species in cultured
cells using fluorescent probes. Method Enzymol. 352:62–71. 2002.
View Article : Google Scholar
|
|
29
|
Draper HH and Hadley M: Malondialdehyde
determination as an index of lipid peroxidation. Methods Enzymol.
186:421–431. 1990. View Article : Google Scholar
|
|
30
|
Stoscheck CM: Quantitation of protein.
Methods Enzymol. 182:50–69. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gravel P: Protein Blotting by the Semidry
method. The Protein Protocols Handbook. 2nd edition. Smith Bryan
John: Humana Press; Totowa, NJ: pp. 321–334. 2002, View Article : Google Scholar
|
|
32
|
Walker JM: Quantification of Proteins on
Polyacrylamide Gels. The Protein Protocols Handbook. 2nd edition.
Smith Bryan John: Humana Press; Totowa, NJ: pp. 237–243. 2002
|
|
33
|
Flower RJ, Cheung HS and Cushman DW:
Quantitative determination of prostaglandins and malondialdehyde
formed by the arachidonate oxygenase (prostaglandin synthetase)
system of bovine seminal vesicle. Prostaglandins. 4:325–341. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sivak-Sears NR, Schwartzbaum JA, Miike R,
Moghadassi M and Wrensch M: Case-control study of use of
nonsteroidal antiinflammatory drugs and glioblastoma multiforme. Am
J Epidemiol. 159:1131–1139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Courad JP, Besse D, Delchambre C, et al:
Acetaminophen distribution in the rat central nervous system. Life
Sci. 69:1455–1464. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rao P and Knaus EE: Evolution of
nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX)
inhibition and beyond. J Pharm Pharm Sci. 11:81s–110s. 2008.
|
|
37
|
Conklin KA: Dietary antioxidants during
cancer chemotherapy: impact on chemotherapeutic effectiveness and
development of side effects. Nutr Cancer. 37:1–18. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Weijl NI, Cleton FJ and Osanto S: Free
radicals and antioxidants in chemotherapy-induced toxicity. Cancer
Treat Rev. 23:209–240. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Salganik IR, Albright DC, Rodgers J, et
al: Dietary antioxidant depletion: enhancement of tumor apoptosis
and inhibition of brain tumor growth in transgenic mice.
Carcinogenesis. 21:909–914. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ristimäki A, Sivula A, Lundin J, et al:
Prognostic significance of elevated cyclooxygenase-2 expression in
breast cancer. Cancer Res. 62:632–635. 2002.PubMed/NCBI
|
|
41
|
Ishibashi M, Bottone FG Jr, Taniura S, et
al: The cyclooxygenase inhibitor indomethacin modulates gene
expression and represses the extracellular matrix protein laminin
gamma1 in human glioblastoma cells. Exp Cell Res. 302:244–252.
2005. View Article : Google Scholar
|
|
42
|
Constantinou C, Papas A and Constantinou
AI: Vitamin E and cancer: An insight into the anticancer activities
of vitamin E isomers and analogs. Int J Cancer. 123:739–752. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ottino P and Duncan JR: Effect of vitamin
E succinate on free radical formation, lipid peroxidation levels
and cyclooxygenase activity in murine melanoma cells. Nutr Res.
17:661–676. 1997. View Article : Google Scholar
|
|
44
|
Stapelberg M, Gellert N, Swettenham E, et
al: Alpha-tocopheryl succinate inhibits malignant mesothelioma by
disrupting the fibroblast growth factor autocrine loop: mechanism
and the role of oxidative stress. J Biol Chem. 280:25369–25376.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Naito Y and Yoshikawa T: Oxidative stress
involvement and gene expression in indomethacin-induced
gastropathy. Redox Rep. 11:243–253. 2006. View Article : Google Scholar
|
|
46
|
Maity P, Bindu S, Dey S, et al:
Indomethacin, a non-steroidal anti-inflammatory grug, develops
gastropathy by inducing reactive oxygen species-mediated
mitochondrial pathology and associated apoptosis in gastric mucosa.
J Biol Chem. 284:3058–3068. 2009. View Article : Google Scholar
|
|
47
|
O’Callaghan JP: Neurotypic and gliotypic
proteins as biochemical markers of neurotoxicity. Neurotoxicol
Teratol. 10:445–452. 1988. View Article : Google Scholar
|
|
48
|
Hrkal Z: On the way to functional
genomics. Sb Lek. 104:217–222. 2003.PubMed/NCBI
|
